These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30242117)

  • 41. Protein structure-based drug design: from docking to molecular dynamics.
    Śledź P; Caflisch A
    Curr Opin Struct Biol; 2018 Feb; 48():93-102. PubMed ID: 29149726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Silico Laboratory: Tools for Similarity-Based Drug Discovery.
    Lešnik S; Konc J
    Methods Mol Biol; 2020; 2089():1-28. PubMed ID: 31773644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Future of Computational Chemogenomics.
    Jacoby E; Brown JB
    Methods Mol Biol; 2018; 1825():425-450. PubMed ID: 30334216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based development of target-specific compound libraries.
    Orry AJ; Abagyan RA; Cavasotto CN
    Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
    Tan L; Batista J; Bajorath J
    Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cheminformatics in the Service of GPCR Drug Discovery.
    James T
    Methods Mol Biol; 2018; 1705():395-411. PubMed ID: 29188575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should network biology be used for drug discovery?
    Martínez-Jiménez F; Marti-Renom MA
    Expert Opin Drug Discov; 2016 Dec; 11(12):1135-1137. PubMed ID: 27635856
    [No Abstract]   [Full Text] [Related]  

  • 48. A scalable and accurate method for classifying protein-ligand binding geometries using a MapReduce approach.
    Estrada T; Zhang B; Cicotti P; Armen RS; Taufer M
    Comput Biol Med; 2012 Jul; 42(7):758-71. PubMed ID: 22658682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis and optimization of structure-based virtual screening protocols (1): exploration of ligand conformational sampling techniques.
    Good AC; Cheney DL
    J Mol Graph Model; 2003 Sep; 22(1):23-30. PubMed ID: 12798388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures.
    Strömbergsson H; Kryshtafovych A; Prusis P; Fidelis K; Wikberg JE; Komorowski J; Hvidsten TR
    Proteins; 2006 Nov; 65(3):568-79. PubMed ID: 16948162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based computational analysis of protein binding sites for function and druggability prediction.
    Nisius B; Sha F; Gohlke H
    J Biotechnol; 2012 Jun; 159(3):123-34. PubMed ID: 22197384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A review of MED-SuMo applications.
    Doppelt-Azeroual O; Moriaud F; Adcock SA; Delfaud F
    Infect Disord Drug Targets; 2009 Jun; 9(3):344-57. PubMed ID: 19519487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combinations of protein-chemical complex structures reveal new targets for established drugs.
    Kalinina OV; Wichmann O; Apic G; Russell RB
    PLoS Comput Biol; 2011 May; 7(5):e1002043. PubMed ID: 21573205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The integration of computational chemistry during drug discovery to drive decisions: are we there yet?
    Desai PV
    Future Med Chem; 2016 Sep; 8(14):1717-20. PubMed ID: 27581125
    [No Abstract]   [Full Text] [Related]  

  • 56. Computational chemistry and computer-aided drug discovery: part 1.
    Bajorath J
    Future Med Chem; 2016 Sep; 8(14):1705-6. PubMed ID: 27603809
    [No Abstract]   [Full Text] [Related]  

  • 57. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
    Morency LP; Gaudreault F; Najmanovich R
    Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. eF-seek: prediction of the functional sites of proteins by searching for similar electrostatic potential and molecular surface shape.
    Kinoshita K; Murakami Y; Nakamura H
    Nucleic Acids Res; 2007 Jul; 35(Web Server issue):W398-402. PubMed ID: 17567616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Solution NMR Spectroscopy in Target-Based Drug Discovery.
    Li Y; Kang C
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28832542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. G-LoSA: An efficient computational tool for local structure-centric biological studies and drug design.
    Lee HS; Im W
    Protein Sci; 2016 Apr; 25(4):865-76. PubMed ID: 26813336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.